Loading...
Header Logo
Keywords
Last Name
Institution

Mr Philip Chukwuka Onyebujoh

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Davies J, Abimiku A, Alobo M, Mullan Z, Nugent R, Schneidman M, Sikhondze W, Onyebujoh P. Sustainable clinical laboratory capacity for health in Africa. Lancet Glob Health. 2017 03; 5(3):e248-e249. PMID: 28108137.
      View in: PubMed
    2. Chirehwa MT, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, McIlleron H, Denti P. Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction. Antimicrob Agents Chemother. 2016 01; 60(1):487-94. PMID: 26552972.
      View in: PubMed
    3. Mthiyane T, Rustomjee R, Pym A, Connolly C, Onyebujoh P, Theron G, Dheda K. Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden. Int J Infect Dis. 2015 Jul; 36:46-53. PMID: 26003404.
      View in: PubMed
    4. Wedajo W, Schön T, Bedru A, Kiros T, Hailu E, Mebrahtu T, Yamuah L, Ängeby K, Werngren J, Onyebujoh P, Dagne K, Aseffa A. A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting. BMC Res Notes. 2014 Aug 10; 7:512. PMID: 25108648.
      View in: PubMed
    5. Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis. 2014 Jul; 14(7):563-71. PMID: 24810491.
      View in: PubMed
    6. McIlleron H, Rustomjee R, Vahedi M, Mthiyane T, Denti P, Connolly C, Rida W, Pym A, Smith PJ, Onyebujoh PC. Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines. Antimicrob Agents Chemother. 2012 Jun; 56(6):3232-8. PMID: 22411614.
      View in: PubMed
    7. Kirenga BJ, Chanda DM, Muwonge CM, Yimer G, Adatu FE, Onyebujoh PC. Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis. Afr J Infect Dis. 2012; 6(2):29-40. PMID: 23878713.
      View in: PubMed
    8. Jaffar S, Lazarus JV, Onyebujoh P, Chakaya J, Garrib A, Mwaba P, Mboup S, Bellis K, Egwaga S, Corrah T, Coutinho A. Health services strengthening in Africa--research is a key component. Trop Med Int Health. 2010 Nov; 15(11):1270-3. PMID: 20731794.
      View in: PubMed
    9. Churchyard GJ, Kaplan G, Fallows D, Wallis RS, Onyebujoh P, Rook GA. Advances in immunotherapy for tuberculosis treatment. Clin Chest Med. 2009 Dec; 30(4):769-82, ix. PMID: 19925966.
      View in: PubMed
    10. Boraschi D, Abebe Alemayehu M, Aseffa A, Chiodi F, Chisi J, Del Prete G, Doherty TM, Elhassan I, Engers H, Gyan B, Harandi AM, Kariuki T, Kironde F, Kouriba B, Langhorne J, Laskay T, Medaglini D, Olesen O, Onyebujoh P, Palma C, Sauerwein R, Sibanda E, Steinhoff U, Tagliabue A, Thiel A, Vahedi M, Troye-Blomberg M. Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities. PLoS Negl Trop Dis. 2008 Jun 25; 2(6):e255. PMID: 18575596.
      View in: PubMed
    11. Onyebujoh PC, Ribeiro I, Whalen CC. Treatment Options for HIV-Associated Tuberculosis. J Infect Dis. 2007 Aug 15; 196 Suppl 1:S35-45. PMID: 17726832.
      View in: PubMed
    12. Blanc FX, Havlir DV, Onyebujoh PC, Thim S, Goldfeld AE, Delfraissy JF. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. J Infect Dis. 2007 Aug 15; 196 Suppl 1:S46-51. PMID: 17624825.
      View in: PubMed
    13. Onyebujoh P, Rodriguez W, Mwaba P. Priorities in tuberculosis research. Lancet. 2006 Mar 18; 367(9514):940-2. PMID: 16546543.
      View in: PubMed
    14. Onyebujoh P, Zumla A, Ribeiro I, Rustomjee R, Mwaba P, Gomes M, Grange JM. Treatment of tuberculosis: present status and future prospects. Bull World Health Organ. 2005 Nov; 83(11):857-65. PMID: 16302043.
      View in: PubMed
    15. Onyebujoh P, Rook GA. Tuberculosis. Nat Rev Microbiol. 2004 Dec; 2(12):930-2. PMID: 15580691.
      View in: PubMed
    16. Johnson JL, Nunn AJ, Fourie PB, Ormerod LP, Mugerwa RD, Mwinga A, Chintu C, Ngwira B, Onyebujoh P, Zumla A. Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis. Int J Tuberc Lung Dis. 2004 Nov; 8(11):1348-54. PMID: 15581204.
      View in: PubMed
    17. Pillai G, Fourie PB, Padayatchi N, Onyebujoh PC, McIlleron H, Smith PJ, Gabriels G. Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market. Int J Tuberc Lung Dis. 1999 Nov; 3(11 Suppl 3):S309-16; discussion S317-21. PMID: 10593710.
      View in: PubMed
    18. Onyebujoh PC, Abdulmumini T, Robinson S, Rook GA, Stanford JL. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa. Respir Med. 1995 Mar; 89(3):199-207. PMID: 7746913.
      View in: PubMed
    19. Rook GA, Onyebujoh P, Stanford JL. Immunoendocrinological hypothesis of HIV infection. Lancet. 1994 Sep 03; 344(8923):681. PMID: 7915362.
      View in: PubMed
    20. Grange JM, Stanford JL, Rook G, Onyebujoh P, Bretscher PA. Tuberculosis and HIV: light after darkness. Thorax. 1994 Jun; 49(6):537-9. PMID: 8016788.
      View in: PubMed
    21. Rook GA, Onyebujoh P, Wilkins E, Ly HM, al Attiyah R, Bahr G, Corrah T, Hernandez H, Stanford JL. A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunology. 1994 Jan; 81(1):149-54. PMID: 8132212.
      View in: PubMed
    22. Rook GA, Onyebujoh P, Stanford JL. TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV. Immunol Today. 1993 Nov; 14(11):568-9. PMID: 7903855.
      View in: PubMed
    23. Stanford JL, Onyebujoh PC, Rook GA, Grange JM, Pozniak A. Old plague, new plague, and a treatment for both? AIDS. 1993 Sep; 7(9):1275-7. PMID: 8216991.
      View in: PubMed
    Onyebujoh's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description